V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006969 | 320003476 | 1.85 | null | Adjuvant (A) | 2019-01-23 | 2019-01-23 | Trial Unspecified | N | Y | 320015586 | TRIAL |
| 320006970 | 320003480 | 1.73 | 57.3 | Curative (C) | 2016-04-29 | 2016-04-29 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320015612 | CISPLATIN + RT |
| 320006971 | 320003482 | null | 89.55 | Palliative (P) | 2018-08-02 | 2018-08-02 | GemCarbo Days 1+8 | N | null | 320015652 | GEMCARBO |
| 320006972 | 320003484 | 1.59 | 57.8 | Palliative (P) | 2018-02-08 | 2018-03-13 | Carboplatin + Liposomal Doxorubicin | N | Y | 320015665 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006973 | 320006594 | 1.77 | null | Palliative (P) | 2016-05-02 | 2016-05-09 | Carboplatin + Liposomal Doxorubicin | 02 | null | 320015740 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006974 | 320006595 | 1.67 | null | Palliative (P) | null | 2017-06-22 | Cisplatin +Fluorouracil (2 wk) | 02 | null | 320015798 | CISPLATIN + FLUOROURACIL |
| 320006975 | 320003509 | 1.69 | 81.5 | Palliative (P) | 2014-07-01 | 2014-07-01 | CETUXIMAB | 02 | N | 320015806 | CETUXIMAB |
| 320006976 | 320003511 | 1.48 | null | Palliative (P) | 2016-11-09 | 2016-11-10 | Trial Unspecified | N | N | 320015815 | TRIAL |
| 320006977 | 320003518 | null | 71.6 | Palliative (P) | 2018-04-27 | 2018-04-27 | GEMCARBO | 02 | N | 320015848 | GEMCARBO |
| 320006978 | 320003522 | 1.61 | 122.8 | Palliative (P) | 2018-05-23 | 2018-05-23 | Cisplatin 7 day | N | null | 320015851 | CISPLATIN |
| 320006979 | 320003543 | 1.7 | null | Palliative (P) | 2017-03-02 | 2017-03-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | 320015945 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006980 | 320003548 | 1.56 | 52 | Curative (C) | 2016-01-02 | 2016-03-08 | CISPLATIN + RT | Y | N | 320015989 | CISPLATIN + RT |
| 320006981 | 320003554 | 1.85 | 78 | Palliative (P) | 2018-02-05 | 2018-03-29 | Trial Unspecified | N | N | 320016065 | TRIAL |
| 320006982 | 320003558 | 1.56 | 19.5 | Palliative (P) | 2016-09-17 | 2016-10-10 | GEMCARBO | N | N | 320016072 | GEMCARBO |
| 320006983 | 320003560 | 1.87 | 82 | Palliative (P) | 2017-04-12 | 2017-04-28 | Carboplatin + Liposomal Doxorubicin | N | N | 320016114 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006984 | 320003564 | 1.53 | 57.3 | Palliative (P) | null | 2015-12-12 | Liposomal Doxorubicin (Caelyx) | N | Y | 320016194 | LIPOSOMAL DOXORUBICIN |
| 320006985 | 320003566 | 1.72 | 68.1 | Palliative (P) | 2018-04-04 | 2018-04-04 | Trial Unspecified | 2 | N | 320016198 | TRIAL |
| 320006986 | 320003570 | 1.65 | null | Palliative (P) | 2016-09-05 | 2016-09-08 | Cetuximab 7 day (>Cycle 2) | N | Y | 320016235 | CETUXIMAB |
| 320006987 | 320005623 | 1.82 | 72.4 | Curative (C) | 2017-10-13 | 2018-11-20 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320016253 | CETUXIMAB |
| 320006988 | 320003571 | 1.61 | 80 | Palliative (P) | 2015-01-17 | 2015-01-18 | GEMCARBO | N | Y | 320016272 | GEMCARBO |
| 320006989 | 320003574 | 1.89 | 81.5 | Palliative (P) | 2018-07-09 | 2018-07-23 | CETUXIMAB | N | N | 320016288 | CETUXIMAB |
| 320006990 | 320003582 | 1.68 | 60 | null | 2015-09-12 | 2015-09-17 | Trial Unspecified | N | N | 320016460 | TRIAL |
| 320006991 | 320005633 | 1.6 | 77 | Palliative (P) | 2017-04-20 | 2017-05-20 | Trial Unspecified | 02 | N | 320016473 | TRIAL |
| 320006992 | 320003589 | 1.7 | 68.5 | Palliative (P) | 2017-09-25 | 2017-10-24 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 320016569 | CISPLATIN + FLUOROURACIL |
| 320006993 | 320003601 | 1.87 | null | Palliative (P) | 2014-12-10 | 2014-12-10 | Trial Unspecified | 2 | N | 320016701 | TRIAL |
| 320006994 | 320003607 | 1.55 | 50 | Palliative (P) | 2018-03-15 | 2018-05-01 | CISPLATIN + RT | N | Y | 320016767 | CISPLATIN + RT |
| 320006995 | 320005650 | 1.59 | 118 | Palliative (P) | 2018-08-23 | 2019-04-11 | GemCarbo Days 1+8 | N | N | 320016797 | GEMCARBO |
| 320006996 | 320003627 | 1.75 | 46.5 | Palliative (P) | 2015-06-02 | 2015-06-22 | Liposomal Doxorubicin (Caelyx) | 02 | N | 320017094 | LIPOSOMAL DOXORUBICIN |
| 320006997 | 320003630 | 1.74 | 72 | Palliative (P) | 2017-02-15 | 2017-03-07 | Liposomal Doxorubicin (Caelyx) | N | N | 320017120 | LIPOSOMAL DOXORUBICIN |
| 320006998 | 320006627 | 1.75 | 106.2 | Adjuvant (A) | 2017-04-29 | 2017-05-21 | Carboplatin + Liposomal Doxorubicin | N | N | 320017217 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006999 | 320003642 | 1.61 | 77.7 | Palliative (P) | 2017-10-03 | 2017-11-23 | Cisplatin 7 day | 02 | N | 320017245 | CISPLATIN |
| 320007000 | 320003645 | 1.63 | 55.1 | Palliative (P) | 2015-10-29 | 2015-12-25 | Cetuximab 14 day | 02 | N | 320017254 | CETUXIMAB |
| 320007001 | 320003651 | null | 79.7 | Palliative (P) | 2017-05-19 | 2017-05-24 | Liposomal Doxorubicin 50mg/m2 | N | Y | 320017319 | LIPOSOMAL DOXORUBICIN |
| 320007002 | 320003658 | 1.67 | 73 | Curative (C) | 2017-03-14 | 2017-04-29 | CISPLATIN + RT | N | N | 320017403 | CISPLATIN + RT |
| 320007003 | 320003664 | 1.55 | 87.6 | Curative (C) | null | 2016-03-28 | CETUXIMAB | N | Y | 320017423 | CETUXIMAB |
| 320007004 | 320003666 | 1.67 | 57.8 | Palliative (P) | 2015-09-06 | 2015-11-02 | Trial Unspecified | N | N | 320017443 | TRIAL |
| 320007005 | 320003672 | 1.55 | 76 | Palliative (P) | 2016-06-03 | 2016-07-04 | CNS LGG 2004 03 cons vinc +cyclo | 02 | N | 320017521 | NOT MATCHED |
| 320007006 | 320003675 | 1.83 | null | Palliative (P) | 2018-01-21 | 2018-02-04 | GemCarbo Days 1+8 | N | N | 320017559 | GEMCARBO |
| 320007007 | 320003678 | 1.87 | null | Palliative (P) | 2016-04-07 | 2016-04-09 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 320017615 | LIPOSOMAL DOXORUBICIN |
| 320007008 | 320003686 | 1.57 | 70.6 | Not known (9) | null | 2016-05-22 | Cisplatin | N | N | 320017683 | CISPLATIN |
| 320007009 | 320005687 | 1.6 | 48.9 | Palliative (P) | 2016-06-16 | 2017-10-28 | Cetuximab 7 day (>Cycle 2) | N | N | 320017733 | CETUXIMAB |
| 320007010 | 320003698 | 1.7 | 82.7 | Adjuvant (A) | 2018-10-03 | 2018-10-05 | NIVOLUMAB | 2 | N | 320017787 | CETUXIMAB + CISPLATIN + FU |
| 320007011 | 320003701 | 1.84 | 76.1 | Palliative (P) | 2016-06-06 | 2016-06-06 | GEMCITABINE | N | null | 320017790 | CAP |
| 320007012 | 320003706 | 1.85 | 81.1 | null | 2017-07-09 | 2019-09-05 | IVA | 02 | N | 320017944 | TCF |
| 320007013 | 320003709 | 1.77 | 36 | Adjuvant (A) | null | 2019-03-24 | GEMCITABINE | N | N | 320017969 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320007014 | 320003716 | 1.85 | null | Disease modification (D) | 2017-10-30 | 2018-01-22 | POMALIDOMIDE | N | N | 320018100 | FLUOROURACIL |
| 320007015 | 320003724 | 1.52 | 71.3 | Palliative (P) | 2017-04-12 | 2017-04-12 | Docetaxel | N | Y | 320018237 | DOXORUBICIN |
| 320007016 | 320006645 | null | 66.1 | Adjuvant (A) | 2019-03-18 | 2019-03-24 | ICON8 TRIAL | N | Y | 320018383 | CAV |
| 320007017 | 320003733 | null | 95 | Palliative (P) | 2015-07-23 | 2015-07-27 | Vinblastine | N | N | 320018416 | VINBLASTINE |
| 320007018 | 320003735 | 1.82 | 68 | Palliative (P) | 2015-09-28 | 2015-11-18 | Gemcitabine weekly | null | N | 320018420 | CARBO + FLUOROURACIL |